KKR Group Finance Co. IX LLC 4. Price & Performance (KKRS)

Private equity firms KKR and Warburg Pincus have submitted a non-binding offer to acquire Gerresheimer AG for €90 per share, valuing the company at approximately €3.37 billion. Gerresheimer produces medical packaging, including devices for weight loss drugs. The deal remains uncertain as negotiations could take weeks to finalize.1

FS KKR Capital Corp. announced a first-quarter 2025 distribution of $0.70 per share, combining base and supplemental payouts. Despite declines in net investment income and asset value in 2024, the company highlighted portfolio stability and $4.8 billion in liquidity, underscoring its resilience amid shifting market conditions.2

KKR and Warburg Pincus are in discussions to acquire Gerresheimer AG, a German medical packaging firm, for €90 per share. The offer follows Gerresheimer’s earlier talks about a potential sale and reflects growing interest in healthcare-related assets. Gerresheimer's shares rose 5% on the news.1